E
eVariant
Combines digital marketing, big data, and analytics into one platform for healthcare providers to improve patient engagement and physician alignment
About eVariant
eVariant operated as a healthcare technology company focused on patient and physician engagement, founded in 2008 by Bill Moschella and Rob Grant. The firm established its niche by providing a cloud-based platform that integrated customer relationship management (CRM), marketing automation, and data analytics specifically for hospitals and healthcare systems. Its primary clients were hospital marketers and physician relations teams at mid-to-large-sized hospital networks across the United States. The company's business model was centered on its 'Patients for Life Platform,' a Software-as-a-Service (SaaS) solution designed to help healthcare providers acquire and retain high-value patients. This was achieved by enabling clients to launch targeted marketing campaigns and providing real-time data on physician referral streams, which allowed for precise analysis of marketing return on investment.
Read full description
The platform's core function was to consolidate consumer, patient, provider, and claims data, and then apply proprietary analytics to yield actionable intelligence. This allowed healthcare systems to identify, guide, and maintain relationships with desired patient demographics and physicians. Key features included a healthcare-specific CRM, a physician relationship management (PRM) tool, and applications for call centers. A significant aspect of the platform was its ability to integrate with a hospital's existing clinical, billing, and other information systems. One of the platform's key selling points was its alignment with Salesforce, leveraging the latter's growing dominance in the enterprise healthcare market. Over its lifetime, eVariant raised approximately $98.8 million in funding from investors including Lightspeed Venture Partners, Goldman Sachs, and McKesson Ventures.
A major milestone in the company's history was its acquisition by Healthgrades in January 2020. The acquisition aimed to create a comprehensive, end-to-end engagement platform for a combined customer base of over 2,000 hospitals and life sciences clients. The merger combined eVariant's CRM and data analytics capabilities with Healthgrades' consumer-facing website and marketing services, offering a more scaled and integrated solution for health systems navigating industry consolidation. Following the transaction, eVariant shareholders retained a minority stake in the newly combined entity.
At a glance
- Status
- Acquired
- Founded
- 2008
- Headquarters
- Farmington, United States
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 61.7/100
- Industry
- Health, Enterprise Software
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Analytics, Data Analytics, CRM, Predictive Analytics, Biotechnology, Patient Care, Hard Tech, DT and LS, science-based
- Business model
- SaaS
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2020 | $0 | — | Health Grades | — |
| SERIES COther financing | Feb 2018 | — | — | Goldman Sachs · Salesforce · McKesson Ventures | — |
Growth signals
Latest recorded traffic for eVariant is 410 monthly website visits, up 156.3% over the last three months. eVariant's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Health Enterprise Partners
Lightspeed Venture Partners
Salesforce Ventures
Series B and later3 investors entered at this stage
McKesson Ventures
Goldman Sachs
Salesforce
Other known investors1 additional known investor
Health Grades
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about eVariant on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See eVariant’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







